Nuclear Radiology: Page 9

SPECT predicts outcomes in brain surgery for epilepsy

By Will Morton

By providing detail on perfusion in the brain, SPECT can predict how long patients with epilepsy will live free of seizures after brain surgery, according to a study published September 30 in the Journal of Nuclear Medicine.

October 4, 2021

ANSTO to build new facility to produce nuclear medicine isotopes

By AuntMinnie.com staff writers

The Australian Nuclear Science and Technology Organisation (ANSTO) has launched an AU$30 million ($22 million U.S.) project to design a new nuclear medicine isotope manufacturing facility to replace its existing facility at Lucas Heights in Sydney.

September 29, 2021

GE rolls out MyoSPECT cardiac nuclear medicine scanner

By AuntMinnie.com staff writers

GE Healthcare is rolling out a new dedicated nuclear medicine scanner called MyoSPECT. The system sports an extended field of view and automated workflow, as well as detectors based on digital cadmium zinc telluride technology.

September 29, 2021

SNMMI updates appropriate use criteria for PSMA PET

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released new guidance for the clinical use of prostate-specific membrane antigen (PSMA)-PET imaging.

September 20, 2021

PET detects activity in early atherosclerosis

By Will Morton

PET imaging has shown that an experimental radiotracer can detect cellular activity in the artery walls of patients with atherosclerosis, according to a study published September 18 in the Journal of Nuclear Medicine.

September 20, 2021

PET tracer predicts response to immunotherapy

By Will Morton

An experimental PET radiotracer can predict whether patients will respond early to new immunotherapy treatments for metastatic skin cancer, according to a study published September 9 in the Journal of Nuclear Medicine.

September 13, 2021

Hermes, Isotopia sign deal on dosimetry

By AuntMinnie.com staff writers

Nuclear medicine software developer Hermes Medical Solutions has signed a collaboration with Isotopia Molecular Imaging to support clinical studies to demonstrate the positive effects of personalized dosimetry and modulated radiopharmaceutical therapy on patient outcomes.

September 6, 2021

Curium files IND application for prostate PET agent

By AuntMinnie.com staff writers

Nuclear medicine firm Curium has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for its copper-64 PSMA I&T diagnostic radiopharmaceutical.

August 23, 2021

New SPECT tracer detects aggressive breast cancer

By Will Morton

A new SPECT tracer based on technetium-99m is safe in patients and can detect metastatic breast cancer -- in a few cases, better than biopsies can, according to a study published August 12 in the Journal of Nuclear Medicine.

August 15, 2021

PET recommended over bone scintigraphy in pediatric sarcoma

By Will Morton

PET imaging is more effective than bone scintigraphy for detecting metastatic disease in children with soft-tissue cancer, according to a study published online August 9 in the European Journal of Cancer.

August 12, 2021

CMS revokes PET infection, inflammation imaging barrier

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) has removed the final coding barrier for F-18 FDG PET imaging of infection and inflammation, according to the Society of Nuclear Medicine and Molecular Imaging.

August 5, 2021

SNMMI supports new legislation to fix PET payment policy

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is throwing its support behind legislation introduced in the U.S. Congress that would change existing reimbursement policy toward PET radiopharmaceuticals.

July 21, 2021

Previous Page

Page 9 of 81

Next Page